Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from zingiberaceae
Reexamination Certificate
2007-03-20
2007-03-20
Hoffman, Susan Coe (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from zingiberaceae
C424S764000
Reexamination Certificate
active
10457033
ABSTRACT:
Methods of treating migrainous headaches and their associated symptoms are provided by administering a composition comprising parthenolide or feverfew sublingually to a patient in need thereof. Treatments are surprisingly effective with low total administered amounts of parthenolide or feverfew. Compositions and unit dose systems are also described.
REFERENCES:
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4460372 (1984-07-01), Campbell et al.
patent: 4758433 (1988-07-01), Johnson et al.
patent: 5332577 (1994-07-01), Gertner et al.
patent: 5384121 (1995-01-01), Rhodes
patent: 5503843 (1996-04-01), Santus et al.
patent: 5744166 (1998-04-01), Illum
patent: 5837289 (1998-11-01), Grasela et al.
patent: 5905089 (1999-05-01), Hwang et al.
patent: 6068999 (2000-05-01), Hendrix
patent: 6103218 (2000-08-01), Brucker et al.
patent: 6217877 (2001-04-01), Weidner
patent: 6224875 (2001-05-01), Bombardelli et al.
patent: 6299900 (2001-10-01), Reed et al.
patent: 6312736 (2001-11-01), Kelly et al.
patent: 6319510 (2001-11-01), Yates
patent: 6328715 (2001-12-01), Dragan et al.
patent: 6410062 (2002-06-01), Callaghan et al.
patent: 6444237 (2002-09-01), Heleen
patent: 6475511 (2002-11-01), Gohlke et al.
patent: 6491940 (2002-12-01), Levin
patent: 6726939 (2004-04-01), Pak
patent: 6967033 (2005-11-01), Spiess
patent: 2001/0004644 (2001-06-01), Levin
patent: 2001/0021400 (2001-09-01), Bombardelli et al.
patent: 2002/0006987 (2002-01-01), Nakayama et al.
patent: 2002/0058077 (2002-05-01), Shen et al.
patent: 2002/0076452 (2002-06-01), Babish et al.
patent: 2002/0077299 (2002-06-01), Babish et al.
patent: 2002/0077350 (2002-06-01), Babish et al.
patent: 2003/0125373 (2003-07-01), Nakshatri et al.
patent: 0553658 (1993-01-01), None
patent: 1086661 (2001-03-01), None
patent: 2166952 (1986-05-01), None
patent: WO92/11857 (1992-07-01), None
patent: WO94/06800 (1994-03-01), None
patent: WO 96/22774 (1996-08-01), None
patent: WO98/39018 (1998-09-01), None
patent: WO 00/18415 (2000-04-01), None
patent: WO00/62764 (2000-10-01), None
patent: WO01/45699 (2001-06-01), None
patent: WO02/09698 (2002-02-01), None
www.harvestfields.netfirms.com/Tea/Info/description—uses.htm; accessed Nov. 18, 2004.
5 pgs, Migraspray General Product Information from website: www.migraspray.com, accessed Mar. 2004.
1pg, Abstract page for Chinese Patent No. CN1372963, 2003.
10 pgs, International Search Report as issued on Apr. 2, 2004.
5 pgs, “Efficacy of feverfew as prophylactic treatment of migraine,” Johnson et al., British Medical Journal, Aug. 31, 1985; vol. 291:569-573.
4 pgs, “Randomised Double-Blind Placebo-Controlled Trial of Feverfew in Migraine Prevention,” Murphy et al., The Lancet, Jul. 23, 1988; 2; 189-192.
2 pgs, “Feverfew for preventing migraine (Cochrane Review),” Pittler et al.,The Cochrane Library,Issue 2, 2003, www.update-software.com.
3 pgs, “Feverfew for Migraine Prophylaxis,” Vogler et al., Cephalalgia 1998, www.jr2.ox.ac.uk/bandolier.
8 pgs, “Herbal Homeopathic Support for the Treatment of Migraine-Type Headache Symptoms,” Blum et al., NatureWell Corporation, Aug. 29, 2001.
7 pgs, “Varietal Improvement of Herbs: Prospects and Challenges,” Conrad Richter, Mar. 3-5, 1996, www.agric.gov.ab.ca/crops.
2 pgs, Nature's Nutrition—“Feverfew,” product page from www.naturesnutrition.com, accessed May 2003.
10 pgs, “Nuclear Factor-kB as a Molecular Target for Migraine Therapy,” Reuter et al, Ann Neurol 2002; 51:507-516.
18 pgs, “Feverfew,” Kemper, Longwood Herbal Task Force, Nov. 9, 1999, 1-18.
10 pgs, “Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review),” Silberstein, American Academy of Neurology 2000; 538-547.
1 pg, NatureWell, Inc.—product page from http:/
aturewell.com/products, accessed Jul. 2002.
2 pgs, Feverfew/Parthenolide; information page from http://www.smarteats.com, accessed Jul. 2002.
5 pgs, “The Healing Herbs,” Michael Castleman, Copyright 1991, pp. 173-176.
8 pgs, “The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkB kinase,” Kwok et al, Chemistry & Biology, 8 (2001) 759-766.
6 pgs, “Prevalence of Migraine Headache in the United States,” Stewart et al, JAMA, Jan. 1, 1992—vol. 267, No. 1: 64-69.
8 pgs, “Migraine Diagnosis and Treatment: Results from the American Migraine Study II,” Lipton et al,Headache2001; 41: 638-645.
5 pgs, “Migraine in the United States,” Lipton et al, NEUROLOGY 43 (Suppl 3) Jun. 1993: S6-S10.
2 pgs, “Current Trends Prevalence of Chronic Migraine Headaches—United States 1980-1989”, MMWR Weekly, May 24, 1991/40(20):331,337-338.
6 pgs, “Incidence of migraine headache: A population-based study in Olmsted County, Minnesota,” Stang et al, Sep. 1992 NEUROLOGY 42 1657-1662.
7 pgs, “A Canadian Population Survey on the Clinical, Epidemiologic and Societal Impact of Migraine & Tension-Type Headache,” Pryse-Phillips et al,Can. J. Neurol. Sci.1992; vol. 19, No. 3: 333-339.
5 pgs, “Assessment of health-related quality of life in migraine,” Dahlof, Cephalalgia 1993; 13:233-7.
6 pgs, “Burden of Migraine in the United States,” Hu et al, Arch Intern Med/vol. 159, Apr. 26, 1999: 813-818.
7 pgs, “Tolerability and Safety of Frovatriptan with Short- and Long-term Use for Treatment of Migraine and in Comparison with Sumatriptan,” Geraud et al,Headache2002;42[suppl2]:S93-S99.
3 pgs, “Migraine Drug Research Heats Up As Market Soars,” Brown, The Scientist 11[11]:1, May 26, 1997.
4 pgs, “Assessing and Understanding Patient Risk,” Fries, Scand J. Rheumatol 1992; Suppl; 92: 21-24.
9 pgs, “Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection,” Lien et al, Am. J. Physiol Gastrointest Liver Physiol 284: G481-G489, 2003.
3 pgs, “Ginger Syrup as an Antiemetic in Early Pregnancy,” Keating et al, Alternative Therapies, Sep./Oct. 2002, vol. 8, No. 5: 89-91.
7 pgs, “Ginger (Zingiber Officinale) in Migraine Headache,” Mustafa et al,Journal of Ethnopharmacology,29 (1990) 267-273.
5 pgs, “Feverfew as a preventive treatment for migraine: a systematic review,” Volger et al, Cephalalgia, 1998; 18:704-708.
2 pgs, “Migraine Mixup,” ABCNews.com, Jun. 24, 2002, American Headache Society meeting presentation by Dr. Joel Saper.
8 pgs, “Psychologic Aspects of Chronic Headache,” Loretta Mueller, Journal of the American Osteopathic Association, Sep. 2000; vol. 100 (9 Suppl): S14-21.
Higgins James W.
Mitchell Russell W.
Roberts Stephen C.
GelStat Corporation
Hoffman Susan Coe
Kagan Binder PLLC
LandOfFree
Compositions and methods of treatment to alleviate or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of treatment to alleviate or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of treatment to alleviate or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3729717